Two-year outcome of thymectomy with or without immunosuppressive treatment in nonthymomatous myasthenia gravis and its effect on regulatory T cells

Journal of the Neurological Sciences
Michala JakubíkováJan Schutzner

Abstract

Myasthenia gravis (MG) is the autoimmune disorder in which the thymus is considered the pathogenic organ. Thymectomy (TE) is a therapeutic option for MG and often ameliorates clinical symptoms. We evaluated clinical features and outcomes after TE in patients without thymoma and the influence of TE with or without concomitant immunotherapy on the CD4(+)CD25(+) regulatory T cell subpopulation of lymphocytes in peripheral blood in defined followed groups of nonthymomatous MG patients. A total of 46 patients with generalized MG who underwent transsternal TE were identified. Neurologic outcomes after TE were favorable for the majority of patients mainly from the group treated with corticosteroids or combined immunosuppressive treatment. TEs with immunosuppressive treatment in MG patients were associated with increased percentages of CD4(+)CD25(+) cells (p<0.001). No significant change in the postoperative levels of CD4(+)CD25(+) cells was observed in thymectomized patients who preoperatively only received pyridostigmine. Also their clinical response to TE after 2 years of follow-up was worst of all followed groups. The exact mechanism by which TE ameliorates symptoms of MG is yet not clear. These observations indicate that increased...Continue Reading

References

Oct 1, 1988·The Journal of Clinical Investigation·G C HarcourtJ Newsom-Davis
Jun 1, 1989·The Annals of Thoracic Surgery·P D HattonR J Cleveland
Dec 1, 1988·Brain, Behavior, and Immunity·A Vincent
Apr 1, 1988·Neurology·B C SolivenL P Rowland
Jul 1, 1987·Annals of Surgery·A E PapatestasA H Aufses
Sep 1, 1984·The Annals of Thoracic Surgery·Y MondenY Kawashima
Aug 1, 1996·The Journal of Experimental Medicine·G X ZhangT Olsson
Aug 1, 1996·The Journal of Experimental Medicine·M AsanoS Sakaguchi
Nov 7, 2001·The Journal of Experimental Medicine·M A Curotto de LafailleJ J Lafaille
Nov 10, 2001·Nature Immunology·R S BystryA G Betz
Nov 1, 2003·Annals of the New York Academy of Sciences·Y HuangA-K Lefvert
Nov 1, 2003·Annals of the New York Academy of Sciences·Gil I WolfeJohn Newsom-Davis
Apr 7, 2004·The Journal of Experimental Medicine·Vissia VigliettaDavid A Hafler
May 31, 2008·Cell·Shimon SakaguchiMasahiro Ono
Jun 24, 2008·Annals of the New York Academy of Sciences·John Newsom-DavisRobin Conwit
Mar 29, 2013·Autoimmunity Reviews·Smadar Gertel-LapterMiriam C Souroujon
Mar 30, 2013·Autoimmunity Reviews·Sonia Berrih-AkninRobert P Lisak
Jul 16, 2013·Journal of Autoimmunity·Lucy S K Walker
Jan 7, 2014·Journal of Autoimmunity·Sonia Berrih-Aknin, Rozen Le Panse
Jun 18, 2014·Journal of Autoimmunity·Sonia Berrih-Aknin

❮ Previous
Next ❯

Citations

Mar 16, 2021·Frontiers in Neurology·Trine H PopperudEmila Kerty
Apr 28, 2021·Neurology India·A S ShreedharaC Sarada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

European Journal of Cardio-thoracic Surgery : Official Journal of the European Association for Cardio-thoracic Surgery
In Kyu ParkKyung Young Chung
Revista de investigación clínica; organo del Hospital de Enfermedades de la Nutrición
Patricio Santillán-Doherty
Annals of the New York Academy of Sciences
Y HuangA-K Lefvert
© 2021 Meta ULC. All rights reserved